2025 Summit

Jennifer Dress, PharmD, BCPP
Clinical Pharmacy Supervisor; Wilkes-Barre VA Medical Center
Jennifer Dress is a Clinical Psychiatric Pharmacist and Clinical Pharmacy Supervisor at the Wilkes-Barre Veteran’s Affairs Medical Center in Wilkes-Barre, Pennsylvania. She earned her Doctor of Pharmacy degree from Wilkes University School of Pharmacy in 2010. She completed a Post-graduate Pharmacy Practice Residency at the Chillicothe VAMC in Chillicothe, Ohio and a Psychiatric Pharmacy Residency at the University of Maryland School of Pharmacy in Baltimore, Maryland. Dr. Dress has been working for the past 15 years in various healthcare settings throughout the hospital. She has provided direct patient care in acute inpatient psychiatry units, outpatient mental health clinics, substance use treatment programs, acute and critical care units, and skilled nursing care units. She has also provided staff education and precepted students and residents throughout these various hospital settings. Finally, she strives to be an unbiased resource for people living with mental health conditions.

Austin Campbell, PharmD, BCPP, FAAPP
Clinical Associate Professor, University of Missouri – Kansas City School of Pharmacy at MU; Adjunct Assistant Professor, University of Missouri School of Medicine 
Dr. Austin Campbell, PharmD, BCPP, FAAPP, is a Clinical Associate Professor at the University of Missouri–Kansas City School of Pharmacy at MU and an adjunct assistant professor with the University of Missouri Medical School. He currently practices as a psychiatric ambulatory care pharmacist in the internal medicine clinic. Dr. Campbell completed a PGY-1 residency at the Kansas City VA Medical Center, followed by a PGY-2 specialty residency in psychiatry at the Center for Behavioral Medicine in Kansas City, before obtaining board certification in psychiatric pharmacy (BCPP). Prior to his current academic appointment, he served as the acute inpatient psychiatric pharmacist for adults and pediatrics at University of Missouri Health Care for more than 11 years. A dedicated educator and leader in psychiatric pharmacy, Dr. Campbell has received multiple awards for his commitment to training students, residents, and fellows. Recognized throughout Missouri for his outreach and educational efforts in psychopharmacology, he collaborates with organizations such as the National Alliance on Mental Illness (NAMI), Crisis Intervention Team (CIT), the Missouri Department of Mental Health, Project ECHO, and the Missouri Center for Excellence in Child Well-Being. In 2025, he was selected as part of the inaugural class of Fellows of the American Association of Psychiatric Pharmacists (FAAPP), acknowledging his significant contributions to both the organization and the field of psychiatric pharmacy.

Steven C. Stoner, PharmD, BCPP, FAAPP
Associate Dean for Student Affairs and Clinical Professor; University of Missouri – Kansas City School of Pharmacy
Dr. Stoner received his Doctor of Pharmacy degree from the University of Nebraska College of Pharmacy in 1994. He has been with UMKC since 1996 following post-doctoral completion of an ASHP Accredited Psychiatric Pharmacy Practice & Administration Residency and a Psychiatric Pharmacy Fellowship at Western Missouri Mental Health Center. In 1997 he was awarded an NCDEU-NIMH Young Investigator Award and in 2001 the CPNP AstraZeneca Clinical Pharmacy Practice Award. Dr. Stoner has been the recipient of teaching and preceptor of the year awards while at UMKC with both the School of Pharmacy and School of Dentistry. Dr. Stoner served as the director of an ASHP accredited psychiatric Pharmacy Practice residency program for 10 years (1998-2008) at the Northwest Missouri Psychiatric Rehabilitation Center in St. Joseph, Missouri. In 2006, he completed the American Association of Colleges of Pharmacy Academic (AACP) Leadership Fellows Program. Dr. Stoner has been a member of AAPP since 1997 and has served on numerous committees, including terms on the Board of Directors as Member-at-Large and President (2010-2011). Dr. Stoner has also served as a member of the Board of Directors for the AAPP Foundation. Dr. Stoner is also a member of the American Association of Colleges of Pharmacy and has served on several committees as well as serving on the AACP Board of Directors (2016-2019), as the Chair of the Council of Sections (2017-2018), and the Chair of the Pharmacy Practice Section (2014-2015). Dr. Stoner was also the 2024 recipient of the Anne Marie Liles Distinguished Service Award from AACP.  He is currently a Clinical Professor and the Associate Dean for Student Affairs, while previously serving as the Department Chair of the Division of Pharmacy Practice and Administration at the UMKC School of Pharmacy.

M. Lindsey Hedgepeth Kennedy, PharmD, BCPS
Clinical Pharmacy Specialist in Psychiatry & Addiction Medicine, UNC Health; Addiction Medicine Program, Department of Psychiatry, UNC School of Medicine
Lindsey Kennedy is a clinical psychiatric pharmacist at UNC Health and an Assistant Clinical Professor for the Department of Psychiatry at the University of North Carolina at Chapel Hill School of Medicine. She earned her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill School of Pharmacy in 2003 and completed a PGY2 Psychiatric Pharmacy Residency at Audie L Murphy VA in San Antonio, Texas in 2007. Dr. Kennedy has worked in a variety of patient care settings: from operating room pharmacy, inpatient neurology, inpatient psychiatry, to community pharmacy. While practicing in an inpatient psychiatric setting, she developed pharmacy subject matter expertise on perinatal issues, eating disorders, severe and persistent mental illnesses, and addiction. Teaching all levels and professions of learners is integral to Dr. Kennedy’s work; she provides over 20 hours of psychopharmacology lectures per year to the UNC Department of Psychiatry residents and fellows in addition to various continuing education offerings. In 2023, she joined the faculty of the Addiction Medicine program at UNC School of Medicine and is the pharmacist subject matter expert for North Carolina Substance Treatment and Recovery Network (NC STAR Network). In her spare time, she continues to practice independent pharmacy with her father in Henderson, NC.

Ben Miskle, PharmD
Clinical Assistant Professor, University of Iowa Carver College of Medicine, University of Iowa College of Pharmacy
Ben Miskle is a Clinical Pharmacy Specialist at University of Iowa Health Care, and a Clinical Assistant Professor at the University of Iowa Carver College of Medicine and University of Iowa College of Pharmacy. Prior to arriving in Iowa, he completed a psychiatric pharmacy residency program at the Chillicothe Veterans Affairs Medical Center, in Chillicothe, Ohio. He has published articles on addiction treatment services across the United States, substance use and stigma in pregnancy, older adult first-time admissions for substance use disorders, and cannabis use disorder treatment to name a few. Dr. Miskle has received multiple grants from the Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA). He runs the integrated access (i-ACCESS) project, for people needing testing and treatment for hepatitis C and HIV while enrolled in substance use disorder treatment across Iowa. He started the Naloxone in Schools (IA-NEXT) project, to assist schools across the state of Iowa on overdose and naloxone education. He is also co-director of The Substance Use Disorder Training Expansion to Advance Multidisciplinary Services in Iowa (SUD-TEAMS-Iowa) project, implementing an evidence-based substance use disorder curriculum in multiple healthcare specialty training programs across Iowa.

Danielle R. Hairston, MD
Psychiatry Residency Program Director, Howard University College of Medicine/Hospital
Dr. Danielle Hairston is a double board-certified psychiatrist, medical educator, and mental wellness advocate. Raised in the DC area, she earned her medical degree at Howard University and completed her residency and C-L fellowship at University of Maryland Medical Center. Now, she serves as Psychiatry Training Director at Howard. Dr. Hairston is the immediate past president of the APA's Black Caucus and a leader in the Black Psychiatrists of America. She speaks nationally and internationally on race and mental health, contributing to publications like "Racism and Psychiatry." She also creates content for Black Psychiatry and co-hosts the podcast "The Next 72 Hours," while consulting on corporate wellness. Her expertise spans areas like resident education, minority representation in medicine, and the impact of structural racism.

Michael Kotlyar, PharmD
Professor, University of Minnesota College of Pharmacy
Michael Kotlyar, PharmD is a Professor at the University of Minnesota in the department of Experimental and Clinical Pharmacology in the College of Pharmacy. He received a PharmD degree from Purdue University and completed a research fellowship at the University of North Carolina at Chapel Hill School of Pharmacy. His research has focused on evaluating various aspects of tobacco dependence including assessing how smoking cessation medication can be used more effectively, how technology can be used to assist with smoking cessation and how the availability of non-combustible or flavored tobacco products are likely to affect tobacco use patterns among people who smoke. His research has been funded primarily by the National Institutes of Health and he is an author on approximately 50 peer-reviewed publications.

Yolanda Evans, MD, MPH
Associate Professor of Pediatrics, University of Washington
Dr. Yolanda Evans is an associate professor in the Department of Pediatrics at the University of Washington. She was born and raised in Anchorage, AK and completed undergraduate studies receiving a BS in Biology at the University of Alaska Anchorage and medical doctorate from Oregon Health Sciences University. After completing residency in Pediatrics at the University of Washington, she completed a fellowship in Adolescent Medicine and MPH at the University of WA. Dr. Evans has served a number of roles including Director of Telemedicine at Seattle Children's Hospital, Division of Adolescent Medicine Clinical Director, and Medical Director for the Adolescent Outpatient Eating Disorders Clinic. In 2023, she became the Head of the Division of Adolescent Medicine at UW. In 2012, she started a telehealth consultation clinic with Alaska Native Tribal Health Consortium and continues to offer clinical care for youth around issues related to reproductive health, contraception, & eating disorders. She co-authored a Seattle Children's Hospital sponsored blog, teenology101, that offered anticipatory guidance to parents of adolescents for over 8 years. Her research includes using technology and social media to improve access to safe, reliable health care for adolescents. In 2024, she became an Ambassador for the AAP's Center of Excellence on Social Media and Youth Mental Health. In her free time, she enjoys dancing and traveling with her husband and 3 kids.

Mikiko Y. Takeda, PharmD, MS, BCACP, FAES
Associate Professor, University of New Mexico College of Pharmacy
Mikiko Takeda is an Associate Professor at the University of New Mexico College of Pharmacy, where she leads instruction on neurological diseases, including headache disorders, chronic pain, complementary and alternative medicine, and biostatistics. As a licensed pharmacist in both Japan and the United States, Dr. Takeda brings a unique set of experiences that are broadly applicable to patient care and research. Specifically, she is a pharmacist clinician with prescriptive authority, allowing her to provide patient care in pain management (e.g., chronic non-cancer pain, migraine headaches) and epilepsy. Recently, Dr. Takeda has also begun offering medication management services for patients with cerebral cavernous malformation who experience headaches and epilepsy. Her research at the University of New Mexico (UNM) Pain Center and the Alcohol and Substance Abuse Program (ASAP) focuses on innovative strategies for the safe administration of medication-assisted therapy (e.g., naloxone) to combat opioid use disorder (OUD). At the UNM Pain Center, the team developed a co-prescribing model for opioids and naloxone as a universal precaution. This model has since been integrated into New Mexico's safe opioid prescribing legislation. Additionally, the team has published research demonstrating that widespread naloxone distribution among individuals with OUD significantly increases overdose reversals, ultimately reducing opioid-related deaths.